One of the routes of administration for β2 Agonist Bronchodilators is ___ administration.
oral
Inhalation is a common route of administration for ___ Agonist Bronchodilators.
β2
1/65
p.6
Modes of Administration for Beta 2 Agonists

One of the routes of administration for β2 Agonist Bronchodilators is ___ administration.

oral

p.6
Modes of Administration for Beta 2 Agonists

Inhalation is a common route of administration for ___ Agonist Bronchodilators.

β2

p.4
Role of Beta 1 and Beta 2 Receptors

Beta 2 selective drugs primarily exert their action on ___ smooth muscle.

respiratory

p.11
Adverse Effects of Xanthine Derivatives

In case of adverse effects from xanthine derivatives, it is important to monitor and inform ___ immediately.

HCP (Healthcare Provider)

p.13
Anticholinergic Drugs in Respiratory Treatment

Anticholinergic drugs are not typically the first-line treatment for ___.

asthma

p.10
Mechanism of Xanthine Derivatives

Xanthine derivatives can interact with substances found in ___, ___, and ___.

tea, coffee, chocolate

p.6
Modes of Administration for Beta 2 Agonists

___ Dose Inhalers (MDI) are a method of administering β2 Agonist Bronchodilators.

Metered

p.12
Signs and Symptoms of Xanthine Toxicity

Early signs of xanthine toxicity include nausea, confusion, irritability, and ___.

restlessness

p.6
Modes of Administration for Beta 2 Agonists

β2 Agonist Bronchodilators can be administered via ___ injection.

subcutaneous

p.12
Signs and Symptoms of Xanthine Toxicity

The therapeutic range for xanthine derivatives is ___ to ___ μg/mL.

10, 20

p.3
Mechanism of Beta 2 Agonists

Stimulation of the β2 receptor inhibits ___ contraction.

smooth-muscle

p.12
Signs and Symptoms of Xanthine Toxicity

Theophylline-induced seizures are a ___ phenomenon.

life-threatening

p.5
Types of Beta 2 Agonist Bronchodilators

The duration of action for LABAs is maintained for ___ hours after inhalation of a single dose.

12

p.13
Anticholinergic Drugs in Respiratory Treatment

Anticholinergic drugs are a cornerstone of controlling bronchoconstriction in ___.

COPD

p.7
Modes of Administration for Beta 2 Agonists

MDIs need to be ___ before being inhaled.

nebulized

p.7
Modes of Administration for Beta 2 Agonists

A ___ or reservoir-like attachment can be used with MDIs to sequester the drug between the MDI and the patient’s mouth.

spacer

p.3
Mechanism of Beta 2 Agonists

Increased cAMP increases the activity of other enzymes such as ___.

protein kinase

p.14
Anticholinergic Drugs in Respiratory Treatment

Higher doses and systemic administration of anticholinergic drugs can cause adverse effects such as dry mouth, constipation, tachycardia, ___, urinary retention, and blurred vision.

confusion

p.9
Considerations for Beta Agonists in Physical Therapy

Beta agonists can lead to ___ stimulation, affecting the heart.

cardiac

p.9
Considerations for Beta Agonists in Physical Therapy

It is important to check for ___ of beta agonists in patients.

overuse

p.4
Role of Beta 1 and Beta 2 Receptors

Beta 2 selective drugs stimulate ___.

bronchodilation

p.2
Role of Beta 1 and Beta 2 Receptors

Stimulation of Beta 2 receptors causes arterial ___ and ___.

vasodilation, bronchodilation

p.13
Anticholinergic Drugs in Respiratory Treatment

Anticholinergic drugs block ___ cholinergic receptors and prevent acetylcholine-induced bronchoconstriction.

muscarinic

p.3
Mechanism of Beta 2 Agonists

Stimulation of the β2 receptor increases the activity of the ___ enzyme.

adenyl cyclase

p.10
Mechanism of Xanthine Derivatives

Xanthine derivatives inhibit the ___ enzyme located in bronchial smooth-muscle cells.

phosphodiesterase (PDE)

p.6
Modes of Administration for Beta 2 Agonists

___ are devices that convert liquid medication into a mist for inhalation, used for β2 Agonist Bronchodilators.

Nebulizers

p.9
Considerations for Beta Agonists in Physical Therapy

Patients using beta agonists may experience ___ or jitteriness.

nervousness

p.11
Adverse Effects of Xanthine Derivatives

Electrolyte imbalances associated with xanthine derivatives include hypokalemia, hypophosphatemia, ___, hypocalcemia/hypercalcemia, and hyperglycemia.

hypomagnesemia

p.2
Role of Beta 1 and Beta 2 Receptors

Beta 2 receptors are found in ___ smooth muscle and ___.

arteriolar, bronchioles

p.7
Modes of Administration for Beta 2 Agonists

Metered Dose Inhalers (MDI) contain the drug in a small ___ canister.

aerosol

p.7
Modes of Administration for Beta 2 Agonists

MDIs release an accurate dose of ___ + drug mixture at high velocity.

propellant

p.10
Mechanism of Xanthine Derivatives

Xanthine derivatives, such as ___, are powerful bronchodilators.

Theophylline

p.14
Anticholinergic Drugs in Respiratory Treatment

At lower doses and with inhalation, anticholinergic drugs are generally ___ well.

tolerated

p.5
Types of Beta 2 Agonist Bronchodilators

Examples of LABAs include ___ and ___.

Salmeterol; Serevent, Advair, Formoterol; Foradil

p.9
Considerations for Beta Agonists in Physical Therapy

Allow increased time to complete aerobic tasks to account for depressed ___ output.

cardiac

p.4
Role of Beta 1 and Beta 2 Receptors

Beta 2 selective drugs have little to no effect on ___ receptors.

cardiac

p.11
Adverse Effects of Xanthine Derivatives

Xanthine derivatives can cause confusion, irritability, ___, seizures, nausea, and abdominal pain.

arrhythmias

p.2
Role of Beta 1 and Beta 2 Receptors

Beta 1 receptors are primarily located in the ___ and their stimulation causes increased ___ and increased ___.

heart, heart rate (HR), contraction

p.7
Modes of Administration for Beta 2 Agonists

MDIs require ___ on the patient’s part to ensure adequate delivery of the drug.

coordination

p.3
Mechanism of Beta 2 Agonists

cAMP acts as an intracellular ___ messenger.

second

p.14
Anticholinergic Drugs in Respiratory Treatment

Higher doses and systemic administration of anticholinergic drugs can cause adverse effects such as dry mouth, constipation, ___, confusion, urinary retention, and blurred vision.

tachycardia

p.10
Mechanism of Xanthine Derivatives

The mechanism of xanthine derivatives likely involves a combination of several ___.

mechanisms

p.14
Anticholinergic Drugs in Respiratory Treatment

Higher doses and systemic administration of anticholinergic drugs can cause adverse effects such as dry mouth, constipation, tachycardia, confusion, ___ retention, and blurred vision.

urinary

p.5
Types of Beta 2 Agonist Bronchodilators

Long-acting β 2 AR agonists (LABAs) are used for ___ therapy.

maintenance

p.9
Considerations for Beta Agonists in Physical Therapy

Beta agonists can cause ___, which is a drop in blood pressure.

hypotension

p.5
Types of Beta 2 Agonist Bronchodilators

Short-acting β 2 AR agonists (SABAs) have an onset of action within ___ minutes.

3

p.5
Types of Beta 2 Agonist Bronchodilators

Examples of SABAs include ___ and ___.

Metaproterenol; Alupent, Albuterol; Ventolin, Proventil

p.9
Considerations for Beta Agonists in Physical Therapy

One risk of long-term beta agonist use is the development of ___ to the medication.

tolerance

p.9
Considerations for Beta Agonists in Physical Therapy

Use ___ to monitor exercise intensity, aiming for a range of 11-13/20 or 3-5/10.

RPE (Rate of Perceived Exertion)

p.13
Anticholinergic Drugs in Respiratory Treatment

Examples of anticholinergic drugs include ___ (Atrovent) and ___ (Spiriva).

Ipratropium, Tiotropium

p.3
Mechanism of Beta 2 Agonists

Stimulation of the β2 receptor increases the production of intracellular ___.

cAMP

p.10
Mechanism of Xanthine Derivatives

The exact mechanism of action for xanthine derivatives is ___.

unclear

p.6
Modes of Administration for Beta 2 Agonists

Dry-powder inhalers (DPI) are a type of ___ for β2 Agonist Bronchodilators.

inhaler

p.12
Signs and Symptoms of Xanthine Toxicity

Patients who are otherwise healthy are unlikely to have significant toxicity with levels below ___ μg/mL.

25

p.5
Types of Beta 2 Agonist Bronchodilators

SABAs peak in effectiveness at ___ hours.

2.5

p.9
Considerations for Beta Agonists in Physical Therapy

Discuss any concerns about beta agonist use with a ___ (HCP).

healthcare provider

p.12
Signs and Symptoms of Xanthine Toxicity

Xanthine toxicity begins if plasma levels exceed ___ μg/mL and becomes serious if levels are greater than ___ μg/mL.

15, 20

p.12
Signs and Symptoms of Xanthine Toxicity

Serious signs of xanthine toxicity include cardiac arrhythmias and ___.

seizures

p.12
Signs and Symptoms of Xanthine Toxicity

Predisposing factors for xanthine toxicity include liver disease, congestive heart failure, age over ___ years, infections such as pneumonia, and concomitant use of other drugs.

55

p.5
Types of Beta 2 Agonist Bronchodilators

SABAs are often referred to as ___ meds.

rescue

p.9
Considerations for Beta Agonists in Physical Therapy

When transferring patients slowly, it is important to incorporate an appropriate ___ period after aerobic exercise.

cool-down

p.9
Considerations for Beta Agonists in Physical Therapy

Monitor and report symptoms of nervousness or jitteriness to a ___ (HCP).

healthcare provider

p.9
Considerations for Beta Agonists in Physical Therapy

One consideration for beta agonists is the potential for ___ irritation or constriction.

bronchial

p.9
Considerations for Beta Agonists in Physical Therapy

A common cardiovascular side effect of beta agonists is ___ tachycardia.

reflexive

p.9
Considerations for Beta Agonists in Physical Therapy

Over ___ on beta agonists is a potential concern for patients.

dependence

Study Smarter, Not Harder
Study Smarter, Not Harder